Psychemedics (PMDI) Stock Price

Psychemedics Price

NASDAQ·CLOSED
2.49
​
Market closed

Revenue at Psychemedics has contracted by 0.4% per year over the past 19 years to 19.69 M USD. Earnings per share have declined at 7.1% per year over the last 14 years. For Psychemedics, the net margin of -9.5% is up versus -18.1% a few years ago. At today's price the dividend yield works out to roughly 5.62%.

Psychemedics stock price

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Psychemedics business model & stock analysis

Psychemedics Corp provides drug testing services analyzing hair samples for drug presence, offering historical usage patterns and approximate drug intake levels. The company charges customers a per-unit fee for each tested sample, including training for sample collection and storage of positive results. Their primary service targets clients needing drug testing solutions, particularly in sectors requiring regular monitoring of substance use. The firm's technology focuses on hair analysis to deliver detailed insights into drug consumption over time. Psychemedics Corp's revenue model is based on per-unit testing fees, with services including sample collection training and storage of positive samples. Customers pay for each sample tested, leveraging the company's hair analysis technology to monitor drug use patterns. The business operates within the drug testing services segment, serving clients who require reliable and historical data on substance abuse. The company's drug testing services are designed for customers seeking detailed historical data on drug use, with results indicating both the amount ingested and usage patterns over time. Psychemedics Corp generates income through fixed fees per sample tested, covering the full service including sample collection training and positive sample storage. Their focus remains on delivering accurate, long-term drug usage insights through hair analysis.

Frequently asked questions about Psychemedics

Converted at the current exchange rate, the Psychemedics share trades at 2.26 EUR (2.49 USD).

The Psychemedics share (PMDI) is listed on 1 stock exchanges, including: NASDAQ (PMD).

The revenue cannot currently be calculated for Psychemedics.

The profit cannot currently be calculated for Psychemedics.

The P/E ratio cannot be calculated for Psychemedics at the moment.

The P/S cannot be calculated for Psychemedics currently.

The Eulerpool Quality Score for Psychemedics is 1/10.

The ISIN of Psychemedics is US7443753048. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The WKN of Psychemedics is 889473. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.

The ticker of Psychemedics is PMDI. The ticker symbol is used to trade Psychemedics shares on the stock exchange.

Fair ValueTerminal
2.27 USD
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Health Care Providers & Services
Number of shares
Employees
Revenue per Employee
96,495.10 USD
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Currency
USD
Initial public offering
Jan 22, 1987
ISIN
US7443753048
Cusip
744375205
Sedol
2974761
Market capitalization
15.21 M USDMicro Cap
52-Week Range
PEG
—
P/E ratio
P/Ee
—
P/S
P/Se
—
EV/EBIT
—
P/B Ratio
2.97
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
-36.28 %
Dividend
Dividend yield
0.00 %
Payout Ratio
131.61 %
Dividend growth Ø5Y
3.71 %
Dividend payments per year
3
Dividend paid since
0 years
Dividend not reduced since
0 years
Dividend increased since
0 years
Dividend withholding tax
30.00 %
Last updated Nov 17, 2026, 3:51 AM

Psychemedics Peer Group

Psychemedics Ticker

NASDAQ · PMD